MEI Pharma Inc Financial Flexibility Index
MEI Pharma Inc financial flexibility index. MEI Pharma Inc (MEIP) has a Financial Flexibility Index of -1.82x as of June 2025. Free cash flow of $-2.46 Million (operating CF $-2.46 Million minus capex $0.00) represents -2% of total liabilities ($1.35 Million). See MEIP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of MEI Pharma Inc (2003–2025)
Financial flexibility index of MEI Pharma Inc from 2003 to 2025. Historical Financial Flexibility Index trend for MEI Pharma Inc across 23 annual periods. Check MEI Pharma Inc (MEIP) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
MEI Pharma Inc Financial Flexibility Index by Year (2003–2025)
MEI Pharma Inc financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for MEI Pharma Inc. For the full cash flow conversion analysis, see MEI Pharma Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -15.39x | $-20.84 Million | $-20.84 Million | $1.35 Million | ▼ -154.9% |
| 2024 | -6.04x | $-50.47 Million | $-50.47 Million | $8.36 Million | ▼ -1007.7% |
| 2023 | -0.55x | $-52.45 Million | $-52.48 Million | $96.19 Million | ▼ -41.7% |
| 2022 | -0.38x | $-48.27 Million | $-48.75 Million | $125.43 Million | ▼ -63.4% |
| 2021 | -0.24x | $-31.26 Million | $-31.96 Million | $132.74 Million | ▼ -188.1% |
| 2020 | 0.27x | $35.15 Million | $34.26 Million | $131.51 Million | ▲ +131.8% |
| 2019 | -0.84x | $-29.21 Million | $-29.42 Million | $34.73 Million | ▼ -116.1% |
| 2018 | -0.39x | $-21.09 Million | $-21.30 Million | $54.20 Million | ▼ -153.5% |
| 2017 | 0.73x | $3.54 Million | $3.49 Million | $4.87 Million | ▲ +122.4% |
| 2016 | -3.24x | $-17.85 Million | $-17.86 Million | $5.51 Million | ▲ +42.7% |
| 2015 | -5.66x | $-28.05 Million | $-28.07 Million | $4.96 Million | ▼ -34.6% |
| 2014 | -4.20x | $-19.40 Million | $-19.45 Million | $4.62 Million | ▲ +29.6% |
| 2013 | -5.97x | $-10.01 Million | $-10.04 Million | $1.68 Million | ▼ -50.7% |
| 2012 | -3.96x | $-7.03 Million | $-7.08 Million | $1.77 Million | ▼ -45.8% |
| 2011 | -2.72x | $-6.45 Million | $-6.50 Million | $2.37 Million | ▲ +52.4% |
| 2010 | -5.72x | $-10.03 Million | $-10.03 Million | $1.75 Million | ▼ -124.3% |
| 2009 | -2.55x | $-10.55 Million | $-10.55 Million | $4.14 Million | ▲ +23.7% |
| 2008 | -3.34x | $-11.50 Million | $-11.50 Million | $3.44 Million | ▲ +22.2% |
| 2007 | -4.29x | $-10.79 Million | $-10.79 Million | $2.51 Million | ▲ +40.5% |
| 2006 | -7.21x | $-9.09 Million | $-9.09 Million | $1.26 Million | ▼ -267.5% |
| 2005 | -1.96x | $-5.58 Million | $-5.58 Million | $2.84 Million | ▲ +53.0% |
| 2004 | -4.18x | $-7.97 Million | $-7.97 Million | $1.91 Million | ▼ -207.2% |
| 2003 | -1.36x | $-1.84 Million | $-1.84 Million | $1.35 Million | — |